Carregant...
Pancreatic cancer: current standards, working towards a new therapeutic approach
Pancreatic cancer is the fourth leading cause of cancer deaths with a 5-year survival of 4–6%. Clinical challenges remain to be addressed, since few promising approaches to treat pancreatic cancer have been reported. Here we discuss the potential of a new biotherapeutic agent composed of a lysosomal...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4086873/ https://ncbi.nlm.nih.gov/pubmed/24621210 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14737140.2014.895937 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|